<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mrj</journal-id><journal-title-group><journal-title xml:lang="ru">Современная ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Modern Rheumatology Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1996-7012</issn><issn pub-type="epub">2310-158X</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/1996-7012-2022-5-108-113</article-id><article-id custom-type="elpub" pub-id-type="custom">mrj-1355</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>Молекулярные механизмы действия неденатурированного коллагена II типа: экспериментальные и клинические данные</article-title><trans-title-group xml:lang="en"><trans-title>Molecular Mechanisms of Action of Undenatured Type II Collagen: Experimental and Clinical Evidence</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7663-710X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Громова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gromova</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ольга Алексеевна Громова</p><p>119333, Москва, ул. Вавилова, 44, корп. 2 </p></bio><bio xml:lang="en"><p>Olga A. Gromova</p><p>44, Vavilov Street, Building 2, Moscow 119333</p></bio><email xlink:type="simple">unesco.gromova@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2659-7998</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Торшин</surname><given-names>И. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Torshin</surname><given-names>I. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>119333, Москва, ул. Вавилова, 44, корп. 2 </p></bio><bio xml:lang="en"><p>44, Vavilov Street, Building 2, Moscow 119333</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6068-3080</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лила</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Lila</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, 34А, </p><p>125993, Москва, ул. Баррикадная, 2/1, стр. 1 </p></bio><bio xml:lang="en"><p>34A, Kashirskoe Shosse, Moscow 115522, </p><p>2/1, Barrikadnaya Street, Building 1, Moscow 125993</p><p> </p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Институт фармакоинформатики Федерального исследовательского центра «Информатика и управление» Российской академии наук</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Institute of Pharmacoinformatics of the Federal Research Center "Computer Science and Management", Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»;&#13;
Кафедра ревматологии ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.A. Nasonova Research Institute of Rheumatology;&#13;
Department of Rheumatology Russian Medical Academy of Continuing Professional Education</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>19</day><month>10</month><year>2022</year></pub-date><volume>16</volume><issue>5</issue><fpage>108</fpage><lpage>113</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Громова О.А., Торшин И.Ю., Лила А.М., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Громова О.А., Торшин И.Ю., Лила А.М.</copyright-holder><copyright-holder xml:lang="en">Gromova O.A., Torshin I.Y., Lila A.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://mrj.ima-press.net/mrj/article/view/1355">https://mrj.ima-press.net/mrj/article/view/1355</self-uri><abstract><p>В лечении заболеваний суставов, в том числе остеоартрита (ОА), перспективным является применение стандартизированных экстрактов неденатурированного коллагена II типа (НК-II). Известно, что НК-II участвует в регулировке врожденного и приобретенного иммунитета (уменьшение аутоиммунных реакций, стимулирующих деградацию хряща) и в снижении активности хронического воспаления (модуляция уровней цитокинов и простагландинов). Воздействие НК-II на дискоидиновые рецепторы хондроцитов способствует предотвращению структурных нарушений соединительной ткани хряща. Экспериментальные и клинические исследования показали, что под влиянием стандартизированного НК-II происходят увеличение доли регуляторных CD4+ Т-клеток, снижение уровней провоспалительных цитокинов, таких как интерлейкин (ИЛ) 1β, ИЛ6, фактор некроза опухоли α, СРБ, простагландинов в крови, а также матриксной металлопротеиназы 3 и экспрессии NF-κB в хряще. Применение НК-II при ОА приводит к значительному уменьшению боли, увеличению объема движений в суставах, улучшению функции суставов по WOMAC и качества жизни.</p></abstract><trans-abstract xml:lang="en"><p>In the treatment of joint diseases, including osteoarthritis (OA), the use of standardized extracts of undenatured type II collagen (UDC-II) is promising. It is known that UDC-II is involved in the regulation of innate and adaptive immunity (reduction of autoimmune reactions that stimulate cartilage degradation) and in the reduction of chronic inflammation activity (modulation of cytokines and prostaglandins). The effect of UDC-II on discoidin receptors of chondrocytes helps to prevent structural disorders of the cartilage connective tissue. Experimental and clinical studies have shown that under the influence of standardized UDC-II, there is an increase in the proportion of regulatory CD4+ T cells, a decrease in the levels of pro-inflammatory cytokines, such as interleukin (IL) 1β, IL6, tumor necrosis factor α, CRP, prostaglandins in the blood, as well as matrix metalloproteinase 3 and NF-κB expression in cartilage. The use of UDC-II in OA leads to a significant reduction in pain, an increase in the range of joint motion, an improvement in joint function according to WOMAC and quality of life.</p><p> </p></trans-abstract><kwd-group xml:lang="ru"><kwd>неденатурированный коллаген II типа</kwd><kwd>остеоартрит</kwd><kwd>гипералгезия</kwd><kwd>цитокины</kwd><kwd>биоинформатика</kwd></kwd-group><kwd-group xml:lang="en"><kwd>undenatured type II collagen</kwd><kwd>osteoarthritis</kwd><kwd>hyperalgesia</kwd><kwd>cytokines</kwd><kwd>bioinformatics</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Статья опубликована при поддержке компании ЗАО «ФармФирма «Сотекс»</funding-statement><funding-statement xml:lang="en">Publication of this article has been supported by Sotex PharmFirma</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Lugo JP, Saiyed ZM, Lane NE. Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study. Nutr J. 2016 Jan 29;15:14. doi: 10.1186/s12937-016-0130-8.</mixed-citation><mixed-citation xml:lang="en">Lugo JP, Saiyed ZM, Lane NE. Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study. Nutr J. 2016 Jan 29;15:14. doi: 10.1186/s12937-016-0130-8.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Громова ОА, Торшин ИЮ, Лила АМ, Шавловская ОА. О перспективах использования неденатурированного коллагена II типа в терапии остеоартрита и других заболеваний суставов. Современная ревматология. 2022;16(4):111-6. doi: 10.14412/1996-7012-2022-4-111-116</mixed-citation><mixed-citation xml:lang="en">Gromova OA, Torshin IYu, Lila AM, Shavlovskaya OA. On the prospects for the use of undenatured type II collagen in the treatment of osteoarthritis and other joint diseases. Sovremennaya Revmatologiya = Modern Rheumatology Journal. 2022;16(4):111-6. (In Russ.). doi: 10.14412/1996-7012-2022-4-111-116</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Klatt AR, Paul-Klausch B, Klinger G, et al. A critical role for collagen II in cartilage matrix degradation: collagen II induces pro-inflammatory cytokines and MMPs in primary human chondrocytes. J Orthop Res. 2009 Jan;27(1):65-70. doi: 10.1002/jor.20716.</mixed-citation><mixed-citation xml:lang="en">Klatt AR, Paul-Klausch B, Klinger G, et al. A critical role for collagen II in cartilage matrix degradation: collagen II induces pro-inflammatory cytokines and MMPs in primary human chondrocytes. J Orthop Res. 2009 Jan;27(1):65-70. doi: 10.1002/jor.20716.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Bagchi D, Misner B, Bagchi M, et al. Effects of orally administered undenatured type II collagen against arthritic inflammatory diseases: a mechanistic exploration. Int J Clin Pharmacol Res. 2002;22(3-4):101-10.</mixed-citation><mixed-citation xml:lang="en">Bagchi D, Misner B, Bagchi M, et al. Effects of orally administered undenatured type II collagen against arthritic inflammatory diseases: a mechanistic exploration. Int J Clin Pharmacol Res. 2002;22(3-4):101-10.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Tong T, Zhao W, Wu YQ, et al. Chicken type II collagen induced immune balance of main subtype of helper T cells in mesenteric lymph node lymphocytes in rats with collagen-induced arthritis. Inflamm Res. 2010 May; 59(5):369-77. doi: 10.1007/s00011-009-0109-4. Epub 2009 Oct 28.</mixed-citation><mixed-citation xml:lang="en">Tong T, Zhao W, Wu YQ, et al. Chicken type II collagen induced immune balance of main subtype of helper T cells in mesenteric lymph node lymphocytes in rats with collagen-induced arthritis. Inflamm Res. 2010 May; 59(5):369-77. doi: 10.1007/s00011-009-0109-4. Epub 2009 Oct 28.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">D’Altilio M, Peal A, Alvey M, et al. Therapeutic efficacy and safety of undenatured type II collagen singly or in combination with glucosamine and chondroitin in arthritic dogs. Toxicol Mech Methods. 2007;17(4):189-96. doi: 10.1080/15376510600910469.</mixed-citation><mixed-citation xml:lang="en">D’Altilio M, Peal A, Alvey M, et al. Therapeutic efficacy and safety of undenatured type II collagen singly or in combination with glucosamine and chondroitin in arthritic dogs. Toxicol Mech Methods. 2007;17(4):189-96. doi: 10.1080/15376510600910469.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Yoshinari O, Moriyama H, Shiojima Y. An overview of a novel, water-soluble undenatured type II collagen (NEXT-II). J Am Coll Nutr. 2015;34(3):255-62. doi: 10.1080/07315724.2014.919541. Epub 2015 Mar 9.</mixed-citation><mixed-citation xml:lang="en">Yoshinari O, Moriyama H, Shiojima Y. An overview of a novel, water-soluble undenatured type II collagen (NEXT-II). J Am Coll Nutr. 2015;34(3):255-62. doi: 10.1080/07315724.2014.919541. Epub 2015 Mar 9.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Sahin K, Kucuk O, Orhan C, et al. Niacinamide and undenatured type II collagen modulates the inflammatory response in rats with monoiodoacetate-induced osteoarthritis. Sci Rep. 2021 Jul 19;11(1):14724. doi: 10.1038/s41598-021-94142-3.</mixed-citation><mixed-citation xml:lang="en">Sahin K, Kucuk O, Orhan C, et al. Niacinamide and undenatured type II collagen modulates the inflammatory response in rats with monoiodoacetate-induced osteoarthritis. Sci Rep. 2021 Jul 19;11(1):14724. doi: 10.1038/s41598-021-94142-3.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Orhan C, Juturu V, Sahin E, et al. Undenatured Type II Collagen Ameliorates Inflammatory Responses and Articular Cartilage Damage in the Rat Model of Osteoarthritis. Front Vet Sci. 2021 Mar 4;8:617789. doi: 10.3389/fvets.2021.617789. eCollection 2021.</mixed-citation><mixed-citation xml:lang="en">Orhan C, Juturu V, Sahin E, et al. Undenatured Type II Collagen Ameliorates Inflammatory Responses and Articular Cartilage Damage in the Rat Model of Osteoarthritis. Front Vet Sci. 2021 Mar 4;8:617789. doi: 10.3389/fvets.2021.617789. eCollection 2021.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Gupta RC, Canerdy TD, Skaggs P, et al. Therapeutic efficacy of undenatured type-II collagen (UC-II) in comparison to glucosamine and chondroitin in arthritic horses. J Vet Pharmacol Ther. 2009 Dec;32(6):577-84. 2009 doi: 10.1111/j.1365-2885.2009.01079.x.</mixed-citation><mixed-citation xml:lang="en">Gupta RC, Canerdy TD, Skaggs P, et al. Therapeutic efficacy of undenatured type-II collagen (UC-II) in comparison to glucosamine and chondroitin in arthritic horses. J Vet Pharmacol Ther. 2009 Dec;32(6):577-84. 2009 doi: 10.1111/j.1365-2885.2009.01079.x.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Stabile M, Samarelli R, Trerotoli P, et al. Evaluation of the Effects of Undenatured Type II Collagen (UC-II) as Compared to Robenacoxib on the Mobility Impairment Induced by Osteoarthritis in Dogs. Vet Sci. 2019 Sep 4;6(3):72. doi: 10.3390/vetsci6030072.</mixed-citation><mixed-citation xml:lang="en">Stabile M, Samarelli R, Trerotoli P, et al. Evaluation of the Effects of Undenatured Type II Collagen (UC-II) as Compared to Robenacoxib on the Mobility Impairment Induced by Osteoarthritis in Dogs. Vet Sci. 2019 Sep 4;6(3):72. doi: 10.3390/vetsci6030072.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Bakilan F, Armagan O, Ozgen M, et al. Effects of Native Type II Collagen Treatment on Knee Osteoarthritis. Eurasian J Med. 2016 Jun;48(2):95-101. doi: 10.5152/eurasianjmed.2015.15030.</mixed-citation><mixed-citation xml:lang="en">Bakilan F, Armagan O, Ozgen M, et al. Effects of Native Type II Collagen Treatment on Knee Osteoarthritis. Eurasian J Med. 2016 Jun;48(2):95-101. doi: 10.5152/eurasianjmed.2015.15030.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Lugo JP, Saiyed ZM, Lane NE. Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study. Nutr J. 2016 Jan 29;15:14. doi: 10.1186/s12937-016-0130-8.</mixed-citation><mixed-citation xml:lang="en">Lugo JP, Saiyed ZM, Lane NE. Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study. Nutr J. 2016 Jan 29;15:14. doi: 10.1186/s12937-016-0130-8.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Garcia-Coronado JM, MartinezOlvera L, Elizondo-Omana RE. Effect of collagen supplementation on osteoarthritis symptoms: a meta-analysis of randomized placebo-controlled trials. Int Orthop. 2019 Mar;43(3):531-8. doi: 10.1007/s00264-018-4211-5.</mixed-citation><mixed-citation xml:lang="en">Garcia-Coronado JM, MartinezOlvera L, Elizondo-Omana RE. Effect of collagen supplementation on osteoarthritis symptoms: a meta-analysis of randomized placebo-controlled trials. Int Orthop. 2019 Mar;43(3):531-8. doi: 10.1007/s00264-018-4211-5.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Varney JL, Fowler JW, Coon CN. Undenatured type II collagen mitigates inflammation and cartilage degeneration in healthy Labrador Retrievers during an exercise regimen. Transl Anim Sci. 2021 May 10;5(2): txab084. doi: 10.1093/tas/txab084.</mixed-citation><mixed-citation xml:lang="en">Varney JL, Fowler JW, Coon CN. Undenatured type II collagen mitigates inflammation and cartilage degeneration in healthy Labrador Retrievers during an exercise regimen. Transl Anim Sci. 2021 May 10;5(2): txab084. doi: 10.1093/tas/txab084.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Lugo JP, Saiyed ZM, Lau FC, et al. Undenatured type II collagen (UC-II®) for joint support: a randomized, double-blind, placebo-controlled study in healthy volunteers. J Int Soc Sports Nutr. 2013 Oct 24;10(1):48. doi: 10.1186/1550-2783-10-48.</mixed-citation><mixed-citation xml:lang="en">Lugo JP, Saiyed ZM, Lau FC, et al. Undenatured type II collagen (UC-II®) for joint support: a randomized, double-blind, placebo-controlled study in healthy volunteers. J Int Soc Sports Nutr. 2013 Oct 24;10(1):48. doi: 10.1186/1550-2783-10-48.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Yoshinari O, Marone PA, Moriyama H, et al. Safety and toxicological evaluation of a novel, water-soluble undenatured type II collagen. Toxicol Mech Methods. 2013 Sep;23(7): 491-9. doi: 10.3109/15376516.2013.781255.</mixed-citation><mixed-citation xml:lang="en">Yoshinari O, Marone PA, Moriyama H, et al. Safety and toxicological evaluation of a novel, water-soluble undenatured type II collagen. Toxicol Mech Methods. 2013 Sep;23(7): 491-9. doi: 10.3109/15376516.2013.781255.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Marone PA, Lau FC, Gupta RC, et al. Safety and toxicological evaluation of undenatured type II collagen. Toxicol Mech Methods. 2010 May;20(4):175-89. doi: 10.3109/15376511003646440.</mixed-citation><mixed-citation xml:lang="en">Marone PA, Lau FC, Gupta RC, et al. Safety and toxicological evaluation of undenatured type II collagen. Toxicol Mech Methods. 2010 May;20(4):175-89. doi: 10.3109/15376511003646440.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Woo M, Song YO, Kang KH, Noh JS. Anti-Obesity Effects of Collagen Peptide Derived from Skate (Raja kenojei) Skin Through Regulation of Lipid Metabolism. Mar Drugs. 2018 Aug 30;16(9):306. doi: 10.3390/md16090306.</mixed-citation><mixed-citation xml:lang="en">Woo M, Song YO, Kang KH, Noh JS. Anti-Obesity Effects of Collagen Peptide Derived from Skate (Raja kenojei) Skin Through Regulation of Lipid Metabolism. Mar Drugs. 2018 Aug 30;16(9):306. doi: 10.3390/md16090306.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Orhan C, Sahin E, Er B, et al. Effects of Exercise Combined with Undenatured Type II Collagen on Endurance Capacity, Antioxidant Status, Muscle Lipogenic Genes in Rats. Animals (Basel). 2021 Mar 17;11(3):851. doi: 10.3390/ani11030851.</mixed-citation><mixed-citation xml:lang="en">Orhan C, Sahin E, Er B, et al. Effects of Exercise Combined with Undenatured Type II Collagen on Endurance Capacity, Antioxidant Status, Muscle Lipogenic Genes in Rats. Animals (Basel). 2021 Mar 17;11(3):851. doi: 10.3390/ani11030851.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Fan R, Hao Y, Liu X, et al. Native Collagen II Relieves Bone Impairment through Improving Inflammation and Oxidative Stress in Ageing db/db Mice. Molecules. 2021 Aug 15; 26(16):4942. doi: 10.3390/molecules26164942.</mixed-citation><mixed-citation xml:lang="en">Fan R, Hao Y, Liu X, et al. Native Collagen II Relieves Bone Impairment through Improving Inflammation and Oxidative Stress in Ageing db/db Mice. Molecules. 2021 Aug 15; 26(16):4942. doi: 10.3390/molecules26164942.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Rui F, Jiawei K, Yuntao H, et al. Undenatured type II collagen prevents and treats osteoarthritis and motor function degradation in T2DM patients and db/db mice. Food Funct. 2021 May 21;12(10):4373-91. doi: 10.1039/d0fo03011b.</mixed-citation><mixed-citation xml:lang="en">Rui F, Jiawei K, Yuntao H, et al. Undenatured type II collagen prevents and treats osteoarthritis and motor function degradation in T2DM patients and db/db mice. Food Funct. 2021 May 21;12(10):4373-91. doi: 10.1039/d0fo03011b.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
